NCT06485063 Myofascial Reorganization on Performance, and Biomechanical, Viscoelastic, and Thermographic Properties of Athletes
| NCT ID | NCT06485063 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of the State of Santa Catarina |
| Condition | Healthy |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-04-15 |
| Primary Completion | 2024-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-04-15 with a primary completion date of 2024-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a two-group randomized clinical trial (includes an experimental and a placebo group) to verify the effects of the Myofascial Reorganization (RMF) compared to the placebo-RMF technique on running performance and thermographic, biomechanical, and viscoelastic proprieties of lower limbs of male triathletes. Data collection will be carried out one week before the first intervention session, and one week after the last intervention session. Anthropometric characteristics (height and weight), lower limbs, and biomechanical, viscoelastic, and thermographic properties will be collected before any exercise tests. After this, the athlete will be submitted to: a 10-minute protocol to verify running economy on the treadmill, followed by an incremental test on the treadmill, and a time to exhaustion test. Evaluation procedures will carried out one week before (0 weeks) and one week after (7th week) the experimental/placebo intervention. Intervention sessions will occur during six weeks, twice a week, each session lasting up to 30 minutes.
Eligibility Criteria
Inclusion Criteria: * Athletes * Age between 18 and 45 years * 2 years of competitive experience * Non-smokers * Training at least 3 times/week intending to compete in at least local competitions * No presenting lower limb surgery in the last 12 months * Not presenting lower limb injury in the last 6 months * Not presenting cerebellar diseases that limit sportive practice * Not presenting brain diseases that limit sportive practice * Not presenting musculoskeletal diseases that limit sportive practice * Not presenting signs of rhabdomyolysis * Not presenting systemic conditions that limit sportive practice * Not presenting metabolic that limits sports practice * Not presenting autoimmune conditions; * Not presenting cardiac conditions. Exclusion Criteria: * Not accomplishing 83,3% (10 of 12 sessions) of the proposed experimental/placebo protocol * Not presenting themselves on the re-test day * Developing a lower limb musculoskeletal injury during the study's ongoing period. * Developing a back injury during the study's ongoing period? * Developing central or peripheral nervous system conditions during the study's ongoing period.
Frequently Asked Questions
Who can join the NCT06485063 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06485063 currently recruiting?
Yes, NCT06485063 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of the State of Santa Catarina to inquire about joining.
Where is the NCT06485063 trial being conducted?
This trial is being conducted at Florianópolis, Brazil.
Who is sponsoring the NCT06485063 clinical trial?
NCT06485063 is sponsored by University of the State of Santa Catarina. The trial plans to enroll 60 participants.